NewSquare Capital’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-444
| Closed | -$30.6K | – | 878 |
|
|
2025
Q2 | $30.6K | Buy |
444
+282
| +174% | +$19.2K | ﹤0.01% | 385 |
|
|
2025
Q1 | $11.2K | Buy |
162
+44
| +37% | +$3.63K | ﹤0.01% | 517 |
|
|
2024
Q4 | $10.2K | Sell |
118
-41,507
| -100% | -$4.49M | ﹤0.01% | 267 |
|
|
2024
Q3 | $4.96M | Buy |
41,625
+3,965
| +11% | +$529K | 0.39% | 85 |
|
|
2024
Q2 | $5.38M | Buy |
37,660
+3,165
| +9% | +$419K | 0.46% | 75 |
|
|
2024
Q1 | $4.43M | Buy |
+34,495
| New | +$4.11M | 0.39% | 84 |
|
|
2023
Q3 | – | Sell |
-140
| Closed | -$11.3K | – | 800 |
|
|
2023
Q2 | $11.3K | Buy |
140
+100
| +250% | +$8.17K | ﹤0.01% | 329 |
|
|
2023
Q1 | $3.18K | Hold |
40
| – | – | ﹤0.01% | 508 |
|
|
2022
Q4 | $2.71K | Buy |
+40
| New | +$2.35K | ﹤0.01% | 446 |
|
|
2022
Q1 | – | Sell |
-236
| Closed | -$13K | – | 439 |
|
|
2021
Q4 | $13K | Hold |
236
| – | – | ﹤0.01% | 270 |
|
|
2021
Q3 | $11K | Hold |
236
| – | – | ﹤0.01% | 267 |
|
|
2021
Q2 | $10K | Hold |
236
| – | – | ﹤0.01% | 264 |
|
|
2021
Q1 | $8K | Hold |
236
| – | – | ﹤0.01% | 259 |
|
|
2020
Q4 | $8K | Hold |
236
| – | – | ﹤0.01% | 253 |
|
|
2020
Q3 | $8K | Hold |
236
| – | – | ﹤0.01% | 242 |
|
|
2020
Q2 | $8K | Hold |
236
| – | – | ﹤0.01% | 235 |
|
|
2020
Q1 | $7K | Buy |
+236
| New | +$7.03K | ﹤0.01% | 257 |
|
|
2016
Q4 | – | Sell |
-120
| Closed | -$2K | – | 409 |
|
|
2016
Q3 | $2K | Buy |
+120
| New | +$2.98K | ﹤0.01% | 452 |
|
|
2013
Q4 | – | Sell |
-210
| Closed | -$4K | – | 260 |
|
|
2013
Q3 | $4K | Buy |
+210
| New | +$3.53K | ﹤0.01% | 203 |
|
Other funds holding NVO
F
